February 2023
Below is a list of highlighted articles published in the February issue of the ERJ, chosen by the Chief Editors and available for you to read now.
Editorials
- Now we know: chronic exposure to air pollutants is a risk factor for the development of idiopathic pulmonary fibrosis
Lucile Sesé, Sergio Harari - Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?
Maria R. Bonsignore, Maria Teresa La Rovere
Reviews and Guidelines
- ERS/ESTS statement on the management of pleural infection in adults
Eihab O. Bedawi, Sara Ricciardi, Maged Hassan, Michael R. Gooseman, Rachelle Asciak, Olalla Castro-Añón, Karin Armbruster, Martina Bonifazi, Sarah Poole, Elinor K. Harris, Stefano Elia, Rafal Krenke, Alessandro Mariani, Nick A. Maskell, Eva Polverino, Jose M. Porcel, Lonny Yarmus, Elizabeth P. Belcher, Isabelle Opitz, Najib M. Rahman - Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis
Mingjin Yang, Yishi Li, Youfan Jiang, Shuliang Guo, Jian-Qing He, Don D. Sin - European Respiratory Society guideline on various aspects of quality in lung cancer care
Torsten Gerriet Blum, Rebecca L. Morgan, Valérie Durieux, Joanna Chorostowska-Wynimko, David R. Baldwin, Jeanette Boyd, Corinne Faivre-Finn, Françoise Galateau-Salle, Fernando Gamarra, Bogdan Grigoriu, Georgia Hardavella, Michael Hauptmann, Erik Jakobsen, Dragana Jovanovic, Paul Knaut, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Riccardo Muhr, Luciano Mutti, Marianne Paesmans, Pippa Powell, Paul Martin Putora, Janette Rawlinson, Anna L. Rich, David Rigau, Dirk de Ruysscher, Jean-Paul Sculier, Arnaud Schepereel, Dragan Subotic, Paul Van Schil, Thomy Tonia, Clare Williams, Thierry Berghmans
Original Research Articles
- A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Jatin Patel, Damon Bass, Albertus Beishuizen, Xavier Bocca Ruiz, Hatem Boughanmi, Anthony Cahn, Hugo Colombo, Gerard J. Criner, Katherine Davy, Javier de-Miguel-Díez, Pablo A. Doreski, Sofia Fernandes, Bruno François, Anubha Gupta, Kate Hanrott, Timothy Hatlen, Dave Inman, John D. Isaacs, Emily Jarvis, Natalia Kostina, Tatiana Kropotina, Jean-Claude Lacherade, Divya Lakshminarayanan, Pedro Martinez-Ayala, Charlene McEvoy, Ferhat Meziani, Mehran Monchi, Sumanta Mukherjee, Rosana Muñoz-Bermúdez, Jessica Neisen, Ciara O'Shea, Gaëtan Plantefeve, Lorrie Schifano, Lee E. Schwab, Zainab Shahid, Michinori Shirano, Julia E. Smith, Eduardo Sprinz, Charlotte Summers, Nicolas Terzi, Mark A. Tidswell, Yuliya Trefilova, Russell Williamson, Duncan Wyncoll, Mark Laytonh - Nintedanib in children and adolescents with fibrosing interstitial lung diseases
Robin Deterding, Lisa R. Young, Emily M. DeBoer, David Warburton, Steven Cunningham, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Mihaela Dumistracel, Elvira Erhardt, Julia Bertulis, Martina Gahlemann, Susanne Stowasser, Matthias Griese for the InPedILD trial investigators - In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes
Rishi Chanderraj, Jennifer M. Baker, Stephen G. Kay, Christopher A. Brown, Kevin J. Hinkle, Daniel J. Fergle, Roderick A. McDonald, Nicole R. Falkowski, Joseph D. Metcalf, Keith S. Kaye, Robert J. Woods, Hallie C. Prescott, Michael W. Sjoding, Robert P. Dickson